| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/26/2011 | US7932080 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/21/2011 | WO2011047180A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | WO2011047047A2 Composites containing polypeptides attached to polysaccharides and molecules |
| 04/21/2011 | WO2011046946A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 04/21/2011 | WO2011044701A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | WO2011044698A1 Multi epitope vaccine for poultry |
| 04/21/2011 | WO2010141953A3 Biomaterials, compositions, and methods |
| 04/21/2011 | WO2010141866A3 Soga polynucleotides and polypeptides and uses thereof |
| 04/21/2011 | WO2010104357A4 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 04/21/2011 | WO2010040508A9 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110092677 Modified transferin-antibody fusion proteins |
| 04/21/2011 | US20110092670 Variants derived from actriib and uses therefor |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | CA2777628A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | CA2777242A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311882A1 Reducing the immunogenicity of fusion proteins |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311854A1 Mutated pseudomonas exotoxins with reduced antigenicity |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2310417A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 04/20/2011 | EP1640455B1 Fluorescent protein |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN102027020A Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 04/20/2011 | CN102021184A Antigenic polypeptides |
| 04/20/2011 | CN102020717A Active factor for enhancing lymphocyte targeting killing tumors and preparation method thereof |
| 04/20/2011 | CN102020716A Gene recombination human collagen fusion peptide segment, preparation method and application thereof |
| 04/20/2011 | CN101570756B New-type label protein and application thereof |
| 04/20/2011 | CN101538550B Helicobacter pylori viable bacteria vector vaccine and special recombination bacteria thereof |
| 04/20/2011 | CN101423555B Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
| 04/20/2011 | CN101418047B Antigen-antibody compound crystal and preparation method thereof and antigen epitope |
| 04/20/2011 | CN101402688B Fusion protein, encoding gene and uses thereof |
| 04/20/2011 | CN101100487B Fusion protein capable of removing HPV E7 protein and its encoding gene and application |
| 04/19/2011 | US7928213 Nucleic acids encoding chimeric CD154 polypeptides |
| 04/19/2011 | US7928195 Poly zinc finger proteins with improved linkers |
| 04/19/2011 | US7928075 Binding agents which inhibit myostatin |
| 04/19/2011 | US7927835 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 04/19/2011 | US7927824 Complex of a chaperone with β-amyloid and methods employing this complex |
| 04/19/2011 | US7927823 Assays using chimeric T1R3 taste receptor polypeptides |
| 04/19/2011 | CA2399047C Reagents and methods useful for detecting diseases of the breast |
| 04/19/2011 | CA2392158C Detergent compositions comprising benefit agents |
| 04/19/2011 | CA2195090C Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 04/14/2011 | WO2011044336A2 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| 04/14/2011 | WO2011043814A2 Fluorescent proteins and uses thereof |
| 04/14/2011 | WO2011043530A1 Glp-1 analog fusions, and composition for preventing or treating diabetes containing the fusions as an active ingredient |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110085939 Node polypeptides for nanostructure assembly |
| 04/14/2011 | CA2774953A1 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308901A2 Cleavage of fusion proteins using Granzyme B protease |
| 04/13/2011 | EP2307452A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 04/13/2011 | EP1941043B1 Method for the recombinant expression of a polypeptide |
| 04/13/2011 | CN102016034A Bacterial toxin vaccine |
| 04/13/2011 | CN102016032A Genes that increase the production of oil in plants, and method of using the same |
| 04/13/2011 | CN102016003A Microbe complex |
| 04/13/2011 | CN102015772A Compositions and methods for inhibiting shiga toxin and shiga-like toxin |
| 04/13/2011 | CN102015771A Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 04/13/2011 | CN102010473A Recombinant oxyntomodulin (OXM) fusion protein, and preparation and application thereof |
| 04/13/2011 | CN101611061B Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 04/13/2011 | CN101509007B Synthesis of LfcinB15-Mag12 encoding gene and expression method in colon bacillus |
| 04/13/2011 | CN101275147B Expression vector and fused protein of human differential initiator 3 and preparation thereof |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/07/2011 | WO2011041691A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2010101355A3 Chimeric protein, method for manufacturing the same, nano-sensor in which the chimeric protein is fixed, and application thereof |
| 04/07/2011 | US20110081658 T1r3 binding assays |
| 04/07/2011 | US20110081357 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | CA2779506A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305818A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2123754B1 CHIMERIC Fc GAMMA RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 04/06/2011 | EP1417237B1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 04/06/2011 | EP1411979B1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/06/2011 | EP1407030B1 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 04/06/2011 | CN102002106A Fusion protein MBP-NAP and preparation method and application thereof |